Stephen From, President and Chief Executive Officer of EyeGate Pharmaceuticals commented, We are delighted with the progress we have made with the development of EGP-437 in uveitis, evidenced by this latest milestone payment under the Valeant agreement. The further advancement of EGP-437 not only in uveitis, but indications such as macular edema and post-cataract surgery pain and inflammation is an important driver of our future growth. We look forward to ongoing collaboration with Valeant in uveitis and to the continued independent development of EGP-437 in other indications. About EyeGate: EyeGate is a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing products for treating diseases and disorders of the eye. The EGP-437 combination product, EyeGates first and only product in clinical trials, incorporates a reformulated topically active corticosteroid, Dexamethasone Phosphate that is delivered into the ocular tissues through EyeGates proprietary innovative drug delivery system, the EyeGate II Delivery System. In addition, EyeGate is developing, through its wholly-owned Jade subsidiary, products using cross-linked thiolated carboxymethyl hyaluronic acid (CMHA-S), a modified form of the natural polymer hyaluronic acid (HA), which possesses unique physical and chemical properties such as hydration and healing properties. The ability of CMHA-S to adhere longer to the ocular surface, resist degradation and protect the ocular surface makes it well-suited for treating various ocular surface injuries. EyeGate intends to initiate a clinical study for Jades lead product candidate for corneal epithelial defects by year-end 2016. For more information, please visit www.EyeGatePharma.com . Safe Harbor Statement: Some of the statements in this press release are forward-looking and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements relating to, among other things, the commercialization efforts and other regulatory or marketing approval efforts pertaining to EyeGates products, including EyeGates EGP-437 combination product and those of Jade, a wholly owned subsidiary of EyeGate, as well as the success thereof, with such approvals or success may not be obtained or achieved on a timely basis or at all. These statements involve risks and uncertainties that may cause results to differ materially from the statements set forth in this press release, including, among other things, certain risk factors described under the heading Risk Factors contained in our Annual Report on Form 10-K filed with the SEC on March 30, 2016, and our Quarterly Report on Form 10-Q, as filed with the SEC on August 10, 2016 or described in our other public filings. A Straightforward Overview On Smart Tactics Of Eye Surgery | Suggestions For Your EyesOur results may also be affected by factors of which we are not currently aware. The forward-looking statements in this press release speak only as of the date of this press release.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/eyegate-receives-additional-milestone-payment-123000236.html
In the more common type, called phacoemulsification phaco, the doctor makes a tiny incision in the eye and breaks up the lens using ultrasound waves. Rarely cataracts need to be removed right away, but this isn’t usually the case. This eye chart test measures how well you see at various distances. Whether or not to have cataract surgery is up to you and your doctor. What are the risks of cataract surgery? Vitamin supplements, which have shown varying results in delaying the progression of cataract. http://www.expertselfpublishing.com/alexanderreynoldstown/2016/08/29/useful-products-for-eye-surgery-trends/Before cataract surgery, your doctor may ask you to temporarily stop taking certain medications that increase the risk of bleeding during surgery. If they do, the lenses may need to be removed. As cataracts develop very slowly most people do not know they have them at first. There are no medications or eye drops that will make cataracts go away—surgery is the only treatment.